Presented by Zambon USA ISHLT Voices returns with another podcast presented by Zambon USA exploring bronchiolitis obliterans syndrome (BOS). BOS is one of the most common forms of chronic lung transplant rejection, and in part three of this series, experts take a deep dive into CLAD phenotype differentiation, current gaps in diagnosis and management of BOS, emerging treatment strategies, and lastly, discuss the advances made in BOS diagnosis and management over the last decade. Steven Hays, MD Medical Director, Advanced Lung Disease and Lung Transplant Programs University of California, San Francisco San Francisco, CA USA Justin P. Rosenheck, DO Clinical Assistant Professor of Internal Medicine Division of Pulmonary, Critical Care and Sleep Medicine, Lung Transplant Program The Ohio State University Wexner Medical Center Columbus, OH USA This episode was created for ISHLT Voices and sponsored by Zambon USA, Ltd. The content of this industry-supported ISHLT Voices podcast is developed entirely by our industry partner, Zambon. This is not an official ISHLT educational program, and therefore is not eligible for CME under the ISHLT.